Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01327937 · ClinicalTrials.gov registry record · Phase 4
A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers
A Phase 4 study of Venous Ulcer, sponsored by Organogenesis.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01327937 is a Phase 4 study of Venous Ulcer that has completed, run by Organogenesis. The registered enrollment target is 30 participants, below the 157-participant average among 11 other Venous Ulcer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01327937, a Phase 4 study of Venous Ulcer, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall study objective is to use microarray technology to identify and characterize the gene expression of multiple relevant genes in biopsies of non-healing venous ulcers.
Conditions Studied
Interventions
- DEVICE Apligraf
- OTHER Standard of Care Dressing Group
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01327937
The ClinicalTrials.gov registry entry for NCT01327937 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 157-participant average among 11 other Venous Ulcer trials with a reported enrollment target (81% lower). The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Apligraf is the first listed.
NCT01327937 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01327937 about?
NCT01327937 is a clinical study titled "A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers". The overall study objective is to use microarray technology to identify and characterize the gene expression of multiple relevant genes in biopsies of non-healing venous ulcers.
What is the current status of trial NCT01327937?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2011-03. Estimated completion is 2013-12.
What conditions does trial NCT01327937 study?
This clinical trial studies the following conditions: Venous Ulcer.
What interventions are being tested in trial NCT01327937?
The interventions under investigation include: Apligraf (DEVICE), Standard of Care Dressing Group (OTHER).
Who is sponsoring clinical trial NCT01327937?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01327937 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Evaluating the Durability of Closure for Venous Leg Ulcers
RECRUITING
-
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
RECRUITING · NA
-
Tissue Repair Gel in Venous Leg Ulcers (US)
RECRUITING · Phase 3
-
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.